Circulating miR-3613-5p but not miR-125b-5p, miR-199a-3p, and miR-451a are biomarkers of endometriosis
Diagnostic accuracy
OA: hybrid
CC0
⤵ 7 in-corpus citations
AI-generated summary
Plasma miR-3613-5p levels were significantly decreased in endometriosis patients, suggesting it is a potential biomarker, unlike miR-125b-5p and miR-199a-3p.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: This study aimed to assess the utility of circulating miR-125b-5p, miR-199a-3p, miR-451a, and miR-3613-5p as biomarkers of endometriosis.
STUDY DESIGN: Patients with stage III or IV of endometriosis according to the revised American Society of Reproductive Medicine (rASRM) staging classification, as well as control women, were recruited. We created a prospective study conducted on a group of 48 patients (n = 25 controls, n = 24 endometriosis) who had laparoscopic surgery. Blood samples were taken and plasma miRNA levels were measured by quantitative real-time polymerase chain reaction (RT-qPCR) and assessed with AUC and ROC curves.
RESULTS: MiR-451a and miR-3613-5p were significantly decreased in the plasma of endometriosis patients. miR-451a had a receiver-operating characteristic (ROC) area under the curve 0.8283 and miR-3613-5p had a ROC area under the curve 0.7617. The concentration of circulating miR-125b-5p and miR-199-3p did not differ between endometriosis patients and controls. Plasma miRNA levels did not change with BMI, smoking status, fertility problems, or menstrual pain according to the VAS scale (p > 0.05).
CONCLUSION: Circulating miR-451a and miR-3613-5p levels significantly differed between endometriosis and controls. However, the levels of miR-451a were discordant with previous studies. Therefore, miR-3613-5p may have better potential as the endometriosis biomarker. Circulating miR-125b-5p and miR-199a-3p cannot be used as reliable markers of endometriosis.
My notes (saved in your browser only)
Outcome instruments
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (31)
- Accurate diagnosis of endometriosis using serum microRNAs via openalex
- A critical appraisal of the circulating levels of differentially expressed microRNA in endometriosis† via openalex
- Analysis of Serum microRNA Profile by Solexa Sequencing in Women With Endometriosis via openalex
- Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis via openalex
- Diagnostic accuracy of serum miR-122 and miR-199a in women with endometriosis via openalex
- Endometriosis-associated infertility: From pathophysiology to tailored treatment via openalex
- Endometriosis, infertility and MicroRNA's: A review via openalex
- Erratum: MicroRNAs in endometriosis biological function and emerging biomarker candidates via openalex
- Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction via openalex
- miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis via openalex
- Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer via openalex
- Plasma microRNAs can be a potential diagnostic biomarker for endometriosis via openalex
- Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis via openalex
- Plasma miRNAs as biomarkers for endometriosis via openalex
- Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer via openalex
- Salivary MicroRNA Signature for Diagnosis of Endometriosis via openalex
- Serum microRNAs as diagnostic markers of endometriosis: a comprehensive array-based analysis via openalex
- The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review via openalex
- W2141948830 via openalex
- W3157624235 via openalex
- W3113172645 via openalex
- W3182064091 via openalex
- W3211116320 via openalex
- W2153780208 via openalex
- W4211069525 via openalex
- W4214754424 via openalex
- W4220849519 via openalex
- W4234160457 via openalex
- W3001041847 via openalex
- W2886514991 via openalex
- W6759477748 via openalex
Cited by (9)
- An update on miRNAs as non-invasive diagnostic markers for endometriosis: Why have we not reached consensus? 2026
- p53-mediated epigenetic regulation in the pathogenesis of endometriosis 2026
- Circulating miRNA as diagnostic tools for gynecological diseases and their applications in biosensor development 2025
- Epigenetics of endometriosis 2025
- Precision Therapeutic and Preventive Molecular Strategies for Endometriosis-Associated Infertility 2025
- Diagnostic accuracy of non-coding RNA for detecting endometriosis: A systematic review and meta-analysis 2025
- Therapeutic application of mesenchymal stem cells in endometriosis 2025
- Circulating microRNAs as Non-Invasive Biomarkers in Endometriosis Diagnosis-A Systematic Review 2024
- miR-375-3p predicts the severity of endometriosis and regulates cellular progression by targeting NOX4 2024
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-15T06:07:33.367182+00:00
License: CC0
· commercial use OK